High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

N/ANot Yet RecruitingNCT07070557

Sohag University100 enrolled

Overview

To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Hemodialysis Patient

Interventions

neutrophil lymphocyte ratio and platelet lymphocyte ratioOTHER

explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients

Eligibility

Sex: ALLMin age: 18 Months

Medical Language ↔ Plain English

Inclusion Criteria: * All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR Exclusion Criteria: * • Patients aged \< 18 years old. * Patient with autoimmune disease. * Patient with liver cirrhosis. * Patients with immunodeficiency. * Patients with malignancy.

Locations (1)

Hemodialysis Unit

Sohag, Sohag Governorate, Egypt

Outcomes

Primary Outcomes

Mortality

The primary outcome measures in the study "High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis" is :- All-cause mortality, encompassing death from any cause These is the endpoint used to evaluate the prognostic significance of NLR and PLR in hemodialysis patients.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.